Evidence map›Paper›PMID 26379940›Full record

ArticleInternational journal of clinical and experimental medicine2015

Chinese medicinal plants for advanced endometriosis after conservative surgery: a prospective, multi-center and controlled trial.

Qing Weng, Zhi-Ming Ding, Xiang-Lin Lv, Dong-Xia Yang, Yao-Zhen Song, Fang-Fang Wang, Ying-Hui Ye, Fan Qu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Endometriosis: where are we and where are we going?Reproduction (Cambridge, England) · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qing WengThe First People's Hospital of Yuhang District Hangzhou 311100, Zhejiang, China.
Zhi-Ming DingWomen's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, Zhejiang, China.
Xiang-Lin LvThe First People's Hospital of Yuhang District Hangzhou 311100, Zhejiang, China.
Dong-Xia YangThe 2nd Hospital, Heilongjiang University of Chinese Medicine Harbin 150000, Heilongjiang, China.
Yao-Zhen SongWomen's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, Zhejiang, China.
Fang-Fang WangWomen's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, Zhejiang, China.
Ying-Hui YeWomen's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, Zhejiang, China.
Fan QuWomen's Hospital, School of Medicine, Zhejiang University Hangzhou 310006, Zhejiang, China ; Faculty of Life Sciences and Medicine, King's College London London, SE5 9NU, UK.
Women's Hospital, School of Medicine, Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The trial was to explore the effects of Chinese medicinal plants (CMP) treatment on the advanced endometriosis (stage III-IV) after conservative surgery. A prospective, multi-center and controlled trial was conducted from June 2012 to September 2013. Sixty-five post-operative women with advanced endometriosis (stage III-IV) after conservative surgery were included in the trial. They had undergone laparoscopic surgical excision of the endometriosis lesions and the diagnosis of endometriosis was confirmed by pathological examination. The patients received either CMP treatment or goserelin acetate sustained-release depot treatment (as comparison) according to the willingness of the patients. In the post-treatment follow-up visit at 6 and 12 months, the patients were respectively undergone ultrasonic and gynecological examinations. The serum levels of cancer antigen 125 (CA-125) and interleukin 18 (IL-18) were also detected in the post-treatment follow-up visit at 12 months. We found that in the post-treatment follow-up visit at 6 months, the recurrence rate of CMP group and comparison group was 1/31 (3.23%) and 1/34 (2.94%), respectively. In the post-treatment follow-up visit at 12 months, the recurrence rate of CMP group and comparison group was 5/31 (16.13%) and 6/34 (17.65%), respectively. There were no significant differences between the two groups (P>0.05). The serum levels of CA-125 and IL-18 significantly decreased in both of the two groups (P<0.05) and no marked differences existed between them on the serum levels of IL-18 (P>0.05). The serum CA-125 levels of CMP group were significantly lower than those of the comparison group (P<0.05). No adverse effect was reported in both of the two groups during the research and the follow-up period. It concluded that CMP showed promise in preventing the recurrence of stage III-IV endometriosis after conservative surgery, although the conclusion is somewhat limited due to the small size of the trial.

Indexed as

cancer antigen 125 (CA-125)Chinese medicinal plants (CMP)endometriosisinterleukin 18 (IL-18)

Identifiers

PMID26379940
PMCPMC4565323
OpenAlexW2419423129

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.